Mediplantex National Pharmaceutical JSC (HNX:MED)
Vietnam
· Delayed Price · Currency is VND 20,400
-2,100 (-9.33%)
At close: Jan 30, 2026
HNX:MED Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Market Capitalization | 253,164 | 291,635 | 322,660 | 335,070 | 260,610 | 187,775 | Upgrade
|
| Market Cap Growth | 55.05% | -9.62% | -3.70% | 28.57% | 38.79% | -23.33% | Upgrade
|
| Enterprise Value | 255,977 | 312,499 | 332,302 | 335,404 | 170,199 | 147,414 | Upgrade
|
| Last Close Price | 20400.00 | 23500.00 | 24660.94 | 24749.42 | 18879.37 | 26565.12 | Upgrade
|
| PE Ratio | 16.57 | 19.10 | 21.16 | 28.53 | 40.94 | 50.11 | Upgrade
|
| PS Ratio | 0.69 | 0.79 | 0.73 | 0.83 | 0.65 | 0.55 | Upgrade
|
| PB Ratio | 0.77 | 0.88 | 0.98 | 1.02 | 0.81 | 1.13 | Upgrade
|
| P/TBV Ratio | 0.77 | 0.88 | 0.98 | 1.02 | 0.81 | 1.13 | Upgrade
|
| P/FCF Ratio | - | - | 8.57 | - | - | 24.24 | Upgrade
|
| P/OCF Ratio | - | - | 6.77 | - | 9.94 | 3.02 | Upgrade
|
| EV/Sales Ratio | 0.70 | 0.85 | 0.75 | 0.83 | 0.42 | 0.43 | Upgrade
|
| EV/EBITDA Ratio | 9.00 | 10.99 | 11.04 | 14.83 | 9.12 | 8.00 | Upgrade
|
| EV/EBIT Ratio | 12.12 | 14.80 | 14.97 | 23.65 | 19.71 | 16.58 | Upgrade
|
| EV/FCF Ratio | -12.70 | - | 8.82 | - | - | 19.03 | Upgrade
|
| Debt / Equity Ratio | 0.10 | 0.10 | 0.08 | 0.20 | 0.28 | 0.41 | Upgrade
|
| Debt / EBITDA Ratio | 1.19 | 1.19 | 0.92 | 2.85 | 4.87 | 3.72 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.74 | - | - | 8.86 | Upgrade
|
| Net Debt / Equity Ratio | 0.01 | 0.01 | -0.08 | 0.00 | -0.26 | -0.16 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.10 | 0.10 | -0.89 | 0.04 | -4.44 | -1.41 | Upgrade
|
| Net Debt / FCF Ratio | -0.14 | -0.14 | -0.71 | -0.01 | 0.91 | -3.34 | Upgrade
|
| Asset Turnover | 0.76 | 0.76 | 0.84 | 0.64 | 0.67 | 0.68 | Upgrade
|
| Inventory Turnover | 3.13 | 3.13 | 3.68 | 3.12 | 3.38 | 3.05 | Upgrade
|
| Quick Ratio | 0.56 | 0.56 | 0.73 | 0.69 | 0.83 | 0.70 | Upgrade
|
| Current Ratio | 1.62 | 1.62 | 1.46 | 1.32 | 1.22 | 1.04 | Upgrade
|
| Return on Equity (ROE) | 4.62% | 4.62% | 4.63% | 3.62% | 2.61% | 2.16% | Upgrade
|
| Return on Assets (ROA) | 2.75% | 2.75% | 2.62% | 1.41% | 0.91% | 1.09% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.76% | 5.07% | 5.51% | 3.93% | 3.35% | 4.09% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.40% | 6.40% | 6.70% | 4.30% | 2.70% | 5.40% | Upgrade
|
| Earnings Yield | 6.03% | 5.24% | 4.72% | 3.50% | 2.44% | 2.00% | Upgrade
|
| FCF Yield | -7.96% | -6.91% | 11.68% | -25.22% | -34.93% | 4.13% | Upgrade
|
| Dividend Yield | 5.88% | - | - | 3.64% | 2.65% | 0.94% | Upgrade
|
| Payout Ratio | 65.38% | 65.38% | 72.28% | 54.72% | 138.49% | 354.43% | Upgrade
|
| Buyback Yield / Dilution | 0.03% | 0.03% | - | -32.18% | -49.59% | 0.05% | Upgrade
|
| Total Shareholder Return | 5.92% | 0.03% | - | -28.54% | -46.94% | 0.99% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.